Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study) Alberto Martínez-Castelao; José Luis Górriz Teruel; Luis D¿Marco; Enrique Garrigós; Gema Fernández-Fresnedo; Eugenia Espinel Garuz; Secundino Cigarrán Guldris; Jesús Arteaga Coloma; Nicolas Roberto Robles Pérez-Monteoliva; José Rafael Esteban de la Rosa; Luis Javier Nieto Iglesias; Alberto Ortiz Arduán; Juan Francisco Navarro-González;

Obesity, chronic kidney disease progression and the role of the adipokine C1q/TNF related protein-3 Diego Barbieri; Marian Goicoechea; Eduardo Verde; Ana García-Prieto; Úrsula Verdalles; Ana Pérez de José; Andrés Delgado; Maria Dolores Sánchez-Niño; Alberto Ortiz;

Interleukin-17A: Potential mediator and therapeutic target in hypertension Raúl R. Rodrigues-Diez; Antonio Tejera-Muñoz; Macarena Orejudo; Laura Marquez-Exposito; Laura Santos-Sanchez; Sandra Rayego-Mateos; Elena Cantero-Navarro; Lucia Tejedor-Santamaria; Vanessa Marchant; Alberto Ortiz; Jesús Egido; Sergio Mezzano; Rafael Selgas; Juan F. Navarro-González; Jose M. Valdivielso; Carolina Lavoz; Marta Ruiz-Ortega;